MINERALOCORTICOID RECEPTOR ANTAGONISM IN CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Gillis, Keith [1 ]
Lees, Jennifer [2 ]
Jardine, Alan [2 ]
Traynor, Jamie [1 ]
Mark, Patrick [2 ]
机构：
[1] Queen Elizabeth Univ Hosp, Glasgow Renal & Transplant Unit, Glasgow, Lanark, Scotland
[2] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2017年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
MP111
引用
收藏
页码：468 / 469
页数：2
相关论文
共 50 条
  • [41] Pathophysiological mechanisms of mineralocorticoid receptor-dependent cardiovascular and chronic kidney disease
    Nishiyama, Akira
    HYPERTENSION RESEARCH, 2019, 42 (03) : 293 - 300
  • [42] Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
    Kovarik, Johannes J.
    Kaltenecker, Christopher C.
    Domenig, Oliver
    Antlanger, Marlies
    Poglitsch, Marko
    Kopecky, Chantal
    Saemann, Marcus D.
    DIABETES THERAPY, 2021, 12 (09) : 2485 - 2498
  • [43] Effect of Mineralocorticoid Receptor Antagonism and ACE Inhibition on Angiotensin Profiles in Diabetic Kidney Disease: An Exploratory Study
    Johannes J. Kovarik
    Christopher C. Kaltenecker
    Oliver Domenig
    Marlies Antlanger
    Marko Poglitsch
    Chantal Kopecky
    Marcus D. Säemann
    Diabetes Therapy, 2021, 12 : 2485 - 2498
  • [44] Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
    Kawanami, Daiji
    Takashi, Yuichi
    Muta, Yoshimi
    Oda, Naoki
    Nagata, Dai
    Takahashi, Hiroyuki
    Tanabe, Makito
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [45] Aldosterone antagonism in chronic kidney disease
    Ponda, Manish P.
    Hostetter, Thomas H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2006, 1 (04): : 668 - 677
  • [46] Mineralocorticoid Receptor Antagonists for Diabetic Kidney Disease
    Rossing, Peter
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (12): : 1696 - 1698
  • [47] Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
    Vodosek Hojs, Nina
    Bevc, Sebastjan
    Ekart, Robert
    Piko, Nejc
    Petreski, Tadej
    Hojs, Radovan
    PHARMACEUTICALS, 2021, 14 (06)
  • [48] Efficacy of Mineralocorticoid Receptor Antagonists on Kidney and Cardiovascular Outcomes in Patients With Chronic Kidney Disease: An Umbrella Review
    Amornritvanich, Porntep
    Anothaisintawee, Thunyarat
    Attia, John
    Mckay, Gareth J.
    Thakkinstian, Ammarin
    KIDNEY MEDICINE, 2025, 7 (02)
  • [49] Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application
    Moedt, Erik
    Wasehuus, Victor S.
    Heerspink, Hiddo J. L.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2025, 40 : i37 - i46
  • [50] Mineralocorticoid receptor blockade-a novel approach to fight hyperkalaemia in chronic kidney disease
    Ritz, E.
    Pitt, B.
    CLINICAL KIDNEY JOURNAL, 2013, 6 (05): : 464 - 468
12345